Immutep Sets the Stage for Promising Investor Conferences

Author: Logan Wright Updated: 04-02-2025 08:01 AM

Immutep's Engagement with Investors at Major Conferences

Immutep Limited (ASX: IMM; NASDAQ: IMMP), a leading name in late-stage immunotherapy, is gearing up to engage with investors in a series of noteworthy conferences. With a focus on innovative treatments for cancer and autoimmune conditions, Immutep's management team is set to present and partake in one-on-one sessions at these events.

Upcoming Conference Schedule

Jones Healthcare and Technology Innovation Conference

Immutep will showcase its advancements at the Jones Healthcare and Technology Innovation Conference. Attendees can expect insights into Immutep's pioneering work scheduled for April 9, 2025, at 4:30 pm ET in Las Vegas, Nevada. This conference serves as a perfect platform for the company to highlight its achievements and plans.

The Citizens Life Sciences Conference

This prestigious gathering will take place on May 8, 2025, at 1:00 pm ET in New York. During this conference, Immutep aims to deepen connections with investors and share progress on its immunotherapeutic developments. The team is enthusiastic about exchanging ideas and showcasing their strategic pathways.

Jefferies Global Healthcare Conference

Adding to a busy calendar, Immutep is scheduled to participate in the Jefferies Global Healthcare Conference on June 4 and 5, 2025, also in New York. Here, the company will provide updates on their innovative treatment options and engage with the broader healthcare investment community.

Insights on Immutep's Mission

Immutep stands at the forefront of biotechnology, with a strong commitment to developing cutting-edge immunotherapies. The company has made significant strides in the understanding of Lymphocyte Activation Gene-3 (LAG-3), allowing for tailored treatment options that modulate the immune response effectively. Through its extensive product portfolio, Immutep is dedicated to providing patients with novel therapies that can change the landscape of treatment for challenging conditions.

Company Contact Information

For Australian Investors and Media:
Catherine Strong, Sodali & Co.
+61 (0)406 759 268; catherine.strong@sodali.com

For U.S. Media Inquiries:
Chris Basta, VP, Investor Relations and Corporate Communications
+1 (631) 318 4000; chris.basta@immutep.com

Frequently Asked Questions

What is Immutep Limited known for?

Immutep Limited is known for its development of advanced immunotherapies aimed at treating cancer and autoimmune diseases.

When and where are the upcoming investor conferences?

The upcoming conferences are the Jones Healthcare and Technology Innovation Conference on April 9, 2025, in Las Vegas, the Citizens Life Sciences Conference on May 8, 2025, in New York, and the Jefferies Global Healthcare Conference on June 4-5, 2025, also in New York.

What is LAG-3?

LAG-3 is a protein that plays a crucial role in downregulating immune responses. Immutep focuses on leveraging this to develop therapies that can help patients with autoimmune diseases and cancer.

How can investors connect with Immutep?

Investors can engage with Immutep during the upcoming conferences or reach out through provided contact information for any inquiries.

Where can I find more information about Immutep?

More information can be obtained from Immutep's website, where they regularly update details about their pipeline and conferences.

About The Author

Dedicated Author and financial expert Logan Wright here, 29 years old. After earning an economics degree, I spent a number of years working in different financial industries. My great passion is enabling everyone, from any background or experience level, to understand and be literate in financial matters.

My books and writings are centered on simplifying difficult financial ideas into doable, understandable guidance. Whether it's retirement planning, investing, or budgeting, I want to arm readers with the information they need to make wise financial choices and realize their financial objectives.

Apart from writing, I also frequently post to financial blogs and organize webinars and workshops targeted at enlightening participants about personal finance. Always, my strategy is to offer concise, doable advice that can truly improve people's lives.

Away from work, I like to read, travel, and sample new foods. My goal is to infuse everything I do with the balance that I think is essential to both financial and personal well-being. By my profession, I want to encourage and enable people to confidently and clearly take charge of their financial futures.

Contact Logan Wright privately here. Or send an email with ATTN: Logan Wright as the subject to contact@investorshangout.com.

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.